Status:
COMPLETED
Construction and Preliminary Application of Mindfulness-based Emotional Regulation Intervention Scheme for Adolescents With Anxiety Disorder and Caregivers
Lead Sponsor:
Zhan Yuxin
Conditions:
Anxiety
Mindfulness
Eligibility:
All Genders
12-50 years
Phase:
NA
Brief Summary
Purpose：Aiming to improve the emotional regulation abilities of adolescents with AD and caregivers, reduce anxiety levels, and play an important role in promoting the recovery of adolescents with AD a...
Eligibility Criteria
Inclusion
- Adolescents aged 12-18 years who meet the diagnostic criteria of the 10th edition of the International Classification of Diseases (ICD-10) and are diagnosed with AD by clinical psychiatrists and have a score of ≥50 on the anxiety self-rating scale;
- Adolescents are treated with benzodiazepines or 5-HT reuptake inhibitors;
- Adolescents are in stable condition and have been hospitalized for at least 6 weeks;
- Adolescents can communicate normally and voluntarily participate in this study;
- The father or mother of the AD adolescent who meets the above inclusion criteria;
- As the main fixed caregiver of the child, they are mainly responsible for daily care work, taking care of the child for ≥5 days per week and taking care of the child for more than 3 months ;
- Informed consent and voluntarily participate in this study.
Exclusion
- The caregiver has severe cognitive impairment, mental illness, and physical illness;
- The AD adolescent and the caregiver have participated in other psychological interventions or researchers within 6 months;
- The AD adolescent cannot continue to cooperate with the study due to worsening of the condition;
- Voluntarily withdraw from the study midway.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2024
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT06550778
Start Date
June 1 2022
End Date
March 1 2024
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harbin Medical University
Daqing, Heilongjiang, China